Growth Hormone to Increase Immune Function in People With HIV
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring Growth Hormone, HIV, AIDS, Thymus, CD4 Cell, Immune System, Treatment Experienced
Eligibility Criteria
Inclusion Criteria: HIV infected CD4 count 400 cells/mm3 or less HIV viral load less than 1000 copies/ml for 1 year prior to study entry; in some cases, viral load up to 5000 copies/ml will be acceptable Taking at least 2 anti-HIV medications Exclusion Criteria: Diabetes Cancer. Patients with some cases of Kaposi's sarcoma or skin cancer will not be excluded. Some (not all) forms of heart disease Carpal Tunnel Syndrome Pregnant or breastfeeding
Sites / Locations
- Gladstone Institute of Virology and Immunology
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Growth Hormone Arm
2
Growth hormone receipt in the first year, post-growth hormone follow-up in the second year
Observation only in the 1st year, GH receipt in the second year